对ADHD症状的D1多巴胺和α2A上腺素受体的同时激活:与甲基酸的比较
Research square
|February 6, 2026
概括
选择性多巴胺和上腺激动剂的结合比甲基酸盐更能改善大鼠的认知功能,特别是在基线缺陷的老鼠中. 这表明了对认知障碍的协同治疗的潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 认知心理学 认知心理学
背景情况:
- 注意缺陷/多动障碍 (ADHD) 通常用甲基酸盐治疗,甲基酸盐是一种具有有限有效性的兴奋剂.
- 甲基酸增加多巴胺和诺亚上腺素,但选择性受体向可能提供更好的疗效和减少副作用.
- 研究用于认知增强的新型治疗点至关重要.
研究的目的:
- 为了比较甲基胺与选择性D1/5多巴胺和α2A上腺激动剂的认知效应.
- 为了评估选择性受体激动剂的联合管理的潜在协同效应.
- 评估对时间顺序记忆,认知灵活性和空间工作记忆的影响.
主要方法:
- 利用动物的行为任务来评估认知功能.
- 给药的甲基酸盐,一种选择性的D1/5多巴胺激动剂 (2-甲基二氨酸) 和一种选择性的α2A上腺激动剂 (guanfacine).
- 评估了单个药物和同时使用的急性作用,包括因其α2A激动因子特性而具有的cannabigerol.
主要成果:
- 同时使用α2A和D1激动剂比甲基酸产生了比甲基酸更大的认知改善.
- 主要在表现较差的基线认知功能的老鼠中观察到性能增强.
- 选择性药物显示出有针对性的认知改善的潜力.
结论:
- 选择性α2A和D1激动剂的同时使用可能会产生协同的认知益处.
- 这些发现支持进一步研究用于治疗认知缺陷的综合疗法.
- 有针对性的方法对认知功能受损的个体可能特别有益.
更多相关视频
07:25Identification of Dopamine D1-Alpha Receptor Within Rodent Nucleus Accumbens by an Innovative RNA In Situ Detection Technology
Published on: March 27, 2018
9.0K
10:19High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
16.8K
相关概念视频
Adrenergic Receptors (Adrenoceptors): Classification
5.0K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
5.0K
Adrenergic Receptors: ɑ Subtype
3.0K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
3.0K
Adrenergic Receptors: β Subtype
3.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.2K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.2K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
1.4K
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
1.4K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.6K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.6K
